JANE PH D HSIAO Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JANE PH D HSIAO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JANE PH D HSIAO. JANE PH D HSIAO is Interim CEO in NON INVASIVE MONITORING SYSTEMS INC /FL/ ($NIMU) and Director in TRANSENTERIX INC. ($TRXC) and Vice Chairman & CTO in Opko Health, Inc. ($EXEG) and in Cocrystal Pharma, Inc. ($BZNE) and Director in Cocrystal Pharma, Inc. ($COCP).
Latest Insider Trading Transactions of JANE PH D HSIAO
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TRXC, COCP, NIMU, EXEG
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | TRXC | ASENSUS SURGICAL, ... | HSIAO JANE PH D | Director | Option Exercise | A | 3.25 | 3,155 | 10,254 | 3,155 | |
| Feb 22 2021 | EXEG | OPKO HEALTH, INC. | HSIAO JANE PH D | Vice Chairman & CTO | Option Exercise | A | 4.81 | 400,000 | 1,924,000 | 400,000 | |
| Oct 02 2020 | TRXC | TRANSENTERIX, INC. | HSIAO JANE PH D | Director | Option Exercise | A | 0.35 | 12,915 | 4,520 | 12,915 | |
| Jun 10 2020 | TRXC | TRANSENTERIX, INC. | HSIAO JANE PH D | Director | Option Exercise | A | 0.82 | 31,250 | 25,625 | 31,250 | |
| Jun 10 2020 | TRXC | TRANSENTERIX, INC. | HSIAO JANE PH D | Director | Grant | A | 0.00 | 22,500 | 0 | 307,664 | 285.2 K to 307.7 K (+7.89 %) |
| Jun 10 2020 | TRXC | TRANSENTERIX, INC. | HSIAO JANE PH D | Director | Grant | A | 0.00 | 7,988 | 0 | 285,164 | 277.2 K to 285.2 K (+2.88 %) |
| Jun 08 2020 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Option Exercise | A | 2.27 | 450,000 | 1,021,500 | 450,000 | |
| Oct 25 2019 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 1.50 | 400,000 | 600,000 | 5,127,404 | 4.7 M to 5.1 M (+8.46 %) |
| Jul 03 2019 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Option Exercise | A | 2.47 | 350,000 | 864,500 | 350,000 | |
| May 10 2019 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 2.04 | 2,783 | 5,677 | 24,475,147 | 24.5 M to 24.5 M (+0.01 %) |
| May 10 2019 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 2.04 | 500 | 1,018 | 24,472,364 | 24.5 M to 24.5 M (0.00 %) |
| May 10 2019 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 2.03 | 6,717 | 13,602 | 24,471,864 | 24.5 M to 24.5 M (+0.03 %) |
| Apr 26 2019 | TRXC | TRANSENTERIX INC. | HSIAO JANE PH D | Director | Option Exercise | A | 1.96 | 29,104 | 57,044 | 29,104 | |
| Apr 26 2019 | TRXC | TRANSENTERIX INC. | HSIAO JANE PH D | Director | Option Exercise | A | 1.96 | 29,104 | 57,044 | 29,104 | |
| Apr 26 2019 | TRXC | TRANSENTERIX INC. | HSIAO JANE PH D | Director | Grant | A | 0.00 | 20,380 | 0 | 3,603,278 | 3.6 M to 3.6 M (+0.57 %) |
| Apr 26 2019 | TRXC | TRANSENTERIX INC. | HSIAO JANE PH D | Director | Grant | A | 0.00 | 20,380 | 0 | 3,603,278 | 3.6 M to 3.6 M (+0.57 %) |
| Feb 05 2019 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Gift | G | 0.00 | 1,000,000 | 0 | 0 | 1000 K to 0 (-100.00 %) |
| Feb 05 2019 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Gift | G | 0.00 | 1,000,000 | 0 | 0 | 1000 K to 0 (-100.00 %) |
| Feb 05 2019 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 4.35 | 30,000 | 130,500 | 4,727,404 | 4.7 M to 4.7 M (+0.64 %) |
| Feb 05 2019 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 4.30 | 20,000 | 86,000 | 4,697,404 | 4.7 M to 4.7 M (+0.43 %) |
| Feb 05 2019 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 7.96 | 10,000 | 79,600 | 24,465,147 | 24.5 M to 24.5 M (+0.04 %) |
| Feb 05 2019 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Gift | G | 0.00 | 831,052 | 0 | 24,455,147 | 25.3 M to 24.5 M (-3.29 %) |
| Dec 27 2018 | NIMU | NON INVASIVE MONIT ... | HSIAO JANE PH D | Interim CEO | Buy | P | 0.07 | 20,883,660 | 1,461,856 | 20,883,660 | 0 to 20.9 M |
| Dec 27 2018 | NIMU | NON INVASIVE MONIT ... | HSIAO JANE PH D | Interim CEO | Buy | P | 0.07 | 4,923,503 | 344,645 | 16,752,074 | 11.8 M to 16.8 M (+41.62 %) |
| Dec 27 2018 | NIMU | NON INVASIVE MONIT ... | HSIAO JANE PH D | Interim CEO | Buy | P | 0.07 | 1,428,571 | 100,000 | 11,828,571 | 10.4 M to 11.8 M (+13.74 %) |
| Dec 27 2018 | NIMU | NON INVASIVE MONIT ... | HSIAO JANE PH D | Interim CEO | Buy | P | 0.07 | 20,883,660 | 1,461,856 | 20,883,660 | 0 to 20.9 M |
| Dec 27 2018 | NIMU | NON INVASIVE MONIT ... | HSIAO JANE PH D | Interim CEO | Buy | P | 0.07 | 4,923,503 | 344,645 | 16,752,074 | 11.8 M to 16.8 M (+41.62 %) |
| Dec 27 2018 | NIMU | NON INVASIVE MONIT ... | HSIAO JANE PH D | Interim CEO | Buy | P | 0.07 | 1,428,571 | 100,000 | 11,828,571 | 10.4 M to 11.8 M (+13.74 %) |
| Nov 13 2018 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Grant | A | 3.49 | 573,066 | 2,000,000 | 25,346,199 | 24.8 M to 25.3 M (+2.31 %) |
| Sep 24 2018 | COCP | Cocrystal Pharma, ... | HSIAO JANE PH D | Director | Option Exercise | A | 2.78 | 50,000 | 139,000 | 50,000 | |
| Jun 22 2018 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Option Exercise | A | 4.46 | 500,000 | 2,230,000 | 500,000 | |
| May 29 2018 | TRXC | TRANSENTERIX INC. | HSIAO JANE PH D | Director | Option Exercise | A | 3.17 | 35,592 | 112,827 | 35,592 | |
| May 29 2018 | TRXC | TRANSENTERIX INC. | HSIAO JANE PH D | Director | Grant | A | 0.00 | 20,362 | 0 | 3,582,898 | 3.6 M to 3.6 M (+0.57 %) |
| Mar 26 2018 | TRXC | TRANSENTERIX INC. | HSIAO JANE PH D | Director | Option Exercise | X | 1.65 | 400,000 | 660,000 | 0 | |
| Mar 26 2018 | TRXC | TRANSENTERIX INC. | HSIAO JANE PH D | Director | Buy | X | 1.65 | 400,000 | 660,000 | 3,562,536 | 3.2 M to 3.6 M (+12.65 %) |
| May 26 2017 | TRXC | TRANSENTERIX INC. | HSIAO JANE PH D | Director | Option Exercise | A | 0.48 | 20,000 | 9,600 | 20,000 | |
| May 12 2017 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 6.93 | 10,000 | 69,300 | 24,773,133 | 24.8 M to 24.8 M (+0.04 %) |
| May 12 2017 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 6.92 | 10,000 | 69,200 | 24,763,133 | 24.8 M to 24.8 M (+0.04 %) |
| May 11 2017 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 6.99 | 10,000 | 69,900 | 24,753,133 | 24.7 M to 24.8 M (+0.04 %) |
| May 11 2017 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 6.98 | 5,665 | 39,542 | 24,743,133 | 24.7 M to 24.7 M (+0.02 %) |
| May 11 2017 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 6.97 | 11,735 | 81,793 | 24,737,468 | 24.7 M to 24.7 M (+0.05 %) |
| May 11 2017 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 6.95 | 2,600 | 18,070 | 24,725,733 | 24.7 M to 24.7 M (+0.01 %) |
| May 11 2017 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 6.94 | 10,000 | 69,400 | 24,723,133 | 24.7 M to 24.7 M (+0.04 %) |
| Jan 05 2017 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Option Exercise | M | 7.61 | 112,500 | 856,125 | 112,500 | |
| Jan 05 2017 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | M | 7.61 | 112,500 | 856,125 | 24,713,133 | 24.6 M to 24.7 M (+0.46 %) |
| Jun 10 2016 | TRXC | TRANSENTERIX INC. | HSIAO JANE PH D | Director | Option Exercise | A | 1.52 | 20,000 | 30,400 | 20,000 | |
| Apr 01 2016 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Option Exercise | A | 10.41 | 450,000 | 4,684,500 | 450,000 | |
| Mar 18 2016 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.70 | 700 | 7,490 | 24,600,633 | 24.6 M to 24.6 M (0.00 %) |
| Mar 18 2016 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.59 | 500 | 5,295 | 24,599,933 | 24.6 M to 24.6 M (0.00 %) |
| Mar 17 2016 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 9.99 | 1,200 | 11,988 | 24,599,433 | 24.6 M to 24.6 M (0.00 %) |
| Mar 16 2016 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.00 | 1,200 | 12,000 | 24,598,233 | 24.6 M to 24.6 M (0.00 %) |
| Mar 16 2016 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.12 | 1,000 | 10,120 | 24,597,033 | 24.6 M to 24.6 M (0.00 %) |
| Mar 16 2016 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.12 | 200 | 2,023 | 24,596,033 | 24.6 M to 24.6 M (0.00 %) |
| Mar 15 2016 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.21 | 1,100 | 11,231 | 24,595,833 | 24.6 M to 24.6 M (0.00 %) |
| Mar 15 2016 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.21 | 100 | 1,021 | 24,594,733 | 24.6 M to 24.6 M (0.00 %) |
| Mar 15 2016 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 9.83 | 900 | 8,847 | 24,594,633 | 24.6 M to 24.6 M (0.00 %) |
| Mar 15 2016 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 9.80 | 300 | 2,940 | 24,593,733 | 24.6 M to 24.6 M (0.00 %) |
| Mar 15 2016 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 9.99 | 1,200 | 11,988 | 24,593,433 | 24.6 M to 24.6 M (0.00 %) |
| Mar 15 2016 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.01 | 1,200 | 12,012 | 24,592,233 | 24.6 M to 24.6 M (0.00 %) |
| Mar 17 2016 | BZNE | Cocrystal Pharma, ... | HSIAO JANE PH D | Buy | P | 0.51 | 1,235,294 | 630,000 | 3,435,294 | 2.2 M to 3.4 M (+56.15 %) | |
| Aug 26 2015 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.84 | 500 | 5,420 | 24,591,033 | 24.6 M to 24.6 M (0.00 %) |
| Aug 26 2015 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.84 | 200 | 2,168 | 24,590,533 | 24.6 M to 24.6 M (0.00 %) |
| Aug 26 2015 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.84 | 1,300 | 14,086 | 24,590,333 | 24.6 M to 24.6 M (+0.01 %) |
| Aug 26 2015 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.82 | 8,500 | 91,970 | 24,589,033 | 24.6 M to 24.6 M (+0.03 %) |
| Aug 26 2015 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.82 | 1,500 | 16,223 | 24,580,533 | 24.6 M to 24.6 M (+0.01 %) |
| Aug 26 2015 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.81 | 3,800 | 41,078 | 24,579,033 | 24.6 M to 24.6 M (+0.02 %) |
| Aug 26 2015 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | P | 10.81 | 4,200 | 45,381 | 24,575,233 | 24.6 M to 24.6 M (+0.02 %) |
| Aug 10 2015 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Option Exercise | M | 8.37 | 87,500 | 732,375 | 262,500 | |
| Aug 10 2015 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Option Exercise | M | 7.61 | 112,500 | 856,125 | 225,000 | |
| Aug 10 2015 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | M | 8.37 | 87,500 | 732,375 | 24,571,033 | 24.5 M to 24.6 M (+0.36 %) |
| Aug 10 2015 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | M | 7.61 | 112,500 | 856,125 | 24,483,533 | 24.4 M to 24.5 M (+0.46 %) |
| Aug 07 2015 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Buy | C | 7.07 | 144,823 | 1,023,899 | 4,617,404 | 4.5 M to 4.6 M (+3.24 %) |
| May 08 2015 | TRXC | TRANSENTERIX INC. | HSIAO JANE PH D | Director | Option Exercise | A | 3.53 | 25,000 | 88,250 | 20,000 | |
| Apr 15 2015 | BZNE | Cocrystal Pharma, ... | HSIAO JANE PH D | Option Exercise | A | 1.17 | 350,000 | 409,500 | 350,000 | ||
| Mar 27 2015 | BZNE | Cocrystal Pharma, ... | HSIAO JANE PH D | Buy | P | 0.92 | 2,200,000 | 2,024,000 | 2,200,000 | 0 to 2.2 M | |
| Mar 19 2015 | EXEG | Opko Health, Inc. | HSIAO JANE PH D | Vice Chairman & CTO | Option Exercise | A | 14.42 | 450,000 | 6,489,000 | 450,000 | |
| Mar 05 2015 | BZNE | Cocrystal Pharma, ... | HSIAO JANE PH D | Option Exercise | M | 0.00 | 53,626,802 | 0 | 0 | ||
| Mar 05 2015 | BZNE | Cocrystal Pharma, ... | HSIAO JANE PH D | Buy | M | 0.00 | 5,496,654 | 0 | 5,496,654 | 0 to 5.5 M |
Page: 1